Merck Sharp & Dohme LLC recalls Merck Emend
- Recalling company
- Merck Sharp & Dohme LLC
- Product
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
- Reason
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 12, 2025
- Reported
- Dec 31, 2025
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 3 - single dose kits
- Lot / codes
- Lot #: Z014503, Exp 11/15/2027
- Company location
- Wilson, NC
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0241-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0241-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.